Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01044212 · ClinicalTrials.gov registry record · NA

Bowel Function After Minimally Invasive Urogynecologic Surgery

A NA study, sponsored by University of Rochester.

Completed
Registry status
NA
Development phase
72
Enrollment target

NCT01044212: Completed NA study, sponsored by University of Rochester.

NCT01044212 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 72 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01044212, a NA study, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
NA
Development phase
72 participants
Enrollment target

Study Summary

The purpose of this study is to assess the effect of a standardized postoperative bowel regimen of over-the-counter medications in subjects undergoing minimally invasive urogynecologic surgery.

Primary Outcome

The time to first post-operative bowel movement was measured in hours after surgery.

Interventions

  • DRUG Docusate
  • DRUG Bowel medications

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2009-11
Est. Completion 2011-02
Phase NA
University of Rochester

636 total trials

What the finished NCT01044212 record still lists

NCT01044212 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 2 interventions - of which Docusate is the first listed.

NCT01044212 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01044212 about?

NCT01044212 is a clinical study titled "Bowel Function After Minimally Invasive Urogynecologic Surgery". The purpose of this study is to assess the effect of a standardized postoperative bowel regimen of over-the-counter medications in subjects undergoing minimally invasive urogynecologic surgery.

What is the current status of trial NCT01044212?

This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2009-11. Estimated completion is 2011-02.

What interventions are being tested in trial NCT01044212?

The interventions under investigation include: Docusate (DRUG), Bowel medications (DRUG).

Who is sponsoring clinical trial NCT01044212?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01044212's enrollment target sits among peer trials

72 1089th of 2000 higher than 899 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02359253 · 72 participants · NA

    Robot Aided Rehabilitation - Intervention

  • NCT02962661 · 72 participants · Phase 1

    Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

  • NCT03113643 · 72 participants · Phase 1

    SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

  • NCT03187535 · 72 participants · NA

    Effect of TEAS on PONV After Spinal Surgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01044212, the US trial registry maintained by the National Library of Medicine. NCT01044212 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.